Cardinal Health Stock Net Asset
CAH Stock | USD 123.42 3.08 2.56% |
Cardinal Health fundamentals help investors to digest information that contributes to Cardinal Health's financial success or failures. It also enables traders to predict the movement of Cardinal Stock. The fundamental analysis module provides a way to measure Cardinal Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardinal Health stock.
Cardinal | Net Asset |
Cardinal Health Company Net Asset Analysis
Cardinal Health's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Cardinal Health Net Asset | 45.12 B |
Most of Cardinal Health's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardinal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cardinal Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Cardinal Health is extremely important. It helps to project a fair market value of Cardinal Stock properly, considering its historical fundamentals such as Net Asset. Since Cardinal Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardinal Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardinal Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition |
Cardinal Total Assets
Total Assets |
|
Based on the recorded statements, Cardinal Health has a Net Asset of 45.12 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Cardinal Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardinal Health's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardinal Health could also be used in its relative valuation, which is a method of valuing Cardinal Health by comparing valuation metrics of similar companies.Cardinal Health is currently under evaluation in net asset category among its peers.
Cardinal Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cardinal Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cardinal Health's managers, analysts, and investors.Environmental | Governance | Social |
Cardinal Health Institutional Holders
Institutional Holdings refers to the ownership stake in Cardinal Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cardinal Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cardinal Health's value.Shares | Jpmorgan Chase & Co | 2024-06-30 | 3.1 M | Bank Of America Corp | 2024-06-30 | 3 M | Legal & General Group Plc | 2024-06-30 | 2.6 M | Northern Trust Corp | 2024-09-30 | 2.6 M | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 2.2 M | Lsv Asset Management | 2024-09-30 | 2.2 M | Amundi | 2024-06-30 | 2.1 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 2.1 M | Norges Bank | 2024-06-30 | 2.1 M | Blackrock Inc | 2024-06-30 | 30.8 M | Vanguard Group Inc | 2024-09-30 | 30.8 M |
Cardinal Fundamentals
Return On Asset | 0.0318 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 31.42 B | ||||
Shares Outstanding | 242.01 M | ||||
Shares Owned By Insiders | 0.25 % | ||||
Shares Owned By Institutions | 89.33 % | ||||
Number Of Shares Shorted | 5.5 M | ||||
Price To Earning | 16.00 X | ||||
Price To Book | 16.07 X | ||||
Price To Sales | 0.13 X | ||||
Revenue | 226.83 B | ||||
Gross Profit | 6.54 B | ||||
EBITDA | 1.98 B | ||||
Net Income | 852 M | ||||
Cash And Equivalents | 4.04 B | ||||
Cash Per Share | 13.32 X | ||||
Total Debt | 5.09 B | ||||
Debt To Equity | 5.63 % | ||||
Current Ratio | 1.04 X | ||||
Book Value Per Share | (13.54) X | ||||
Cash Flow From Operations | 3.76 B | ||||
Short Ratio | 3.30 X | ||||
Earnings Per Share | 5.19 X | ||||
Price To Earnings To Growth | 1.02 X | ||||
Target Price | 123.82 | ||||
Number Of Employees | 47.92 K | ||||
Beta | 0.62 | ||||
Market Capitalization | 29.12 B | ||||
Total Asset | 45.12 B | ||||
Retained Earnings | (286 M) | ||||
Working Capital | (756 M) | ||||
Current Asset | 21.96 B | ||||
Current Liabilities | 19.7 B | ||||
Annual Yield | 0.02 % | ||||
Five Year Return | 3.61 % | ||||
Net Asset | 45.12 B | ||||
Last Dividend Paid | 2.01 |
About Cardinal Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardinal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardinal Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardinal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:Check out Cardinal Health Piotroski F Score and Cardinal Health Altman Z Score analysis. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 48.135 | Dividend Share 2.012 | Earnings Share 5.19 | Revenue Per Share 921.782 | Quarterly Revenue Growth (0.04) |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.